Rxwire
In the news · 48h FDA 38 Eli Lilly 17 Roche 9 Merck & Co. (MSD) 7 Johnson & Johnson 4 AbbVie 3 AstraZeneca 3 Daiichi Sankyo 2
Approvals & regulatory · first seen 13h ago, updated 13h ago

FDA Panel Narrowly Backs Multi-Cancer Blood Test Despite Doubts It Works

1 outlet FDA

THURSDAY, Sept. 24, 2026 — A blood test that aims to catch more than 50 types of cancer before symptoms appear narrowly won the backing of U.S. Food and Drug Administration (FDA) advisers Wednesday, even as several doubted it works.The test…

Summary from Drugs.com Medical News.

Coverage 1 article · 1 outlet

  1. Drugs.com Medical News
    FDA Panel Narrowly Backs Multi-Cancer Blood Test Despite Doubts It Works